| 11/16/2026 11:11 AM | GordonMD Global Investments LP (2039349) Filed by Kyverna Therapeutics (1994702) Subject | Form SCHEDULE 13G/A | |
| 11/12/2026 7:01 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2026 7:04 AM | Kyverna Therapeutics (1994702) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/19/2026 1:29 PM | HIRSCHMAN ORIN (1131362) Filed by Kyverna Therapeutics (1994702) Subject | Form SCHEDULE 13G | |
| 09/24/2026 5:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 6:00 AM | Bain Capital Life Sciences Opportunities III, LP (1950105) Filed by Kyverna Therapeutics (1994702) Subject | Form SCHEDULE 13G/A | |
| 08/11/2026 3:04 PM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/09/2026 5:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2026 3:30 PM | Cohen Fred E (1339358) Reporting Kyverna Therapeutics (1994702) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:30 PM | CLARK IAN T (1336504) Reporting Kyverna Therapeutics (1994702) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KYTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/12/2026 3:05 PM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:30 PM | Dac Nadia (1773151) Reporting Kyverna Therapeutics (1994702) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 3:30 PM | Dac Nadia (1773151) Reporting Kyverna Therapeutics (1994702) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/04/2026 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/22/2026 6:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/20/2026 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 3:37 PM | Kyverna Therapeutics (1994702) Subject Walker Karen Marie (2008556) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/14/2026 3:38 PM | Kyverna Therapeutics (1994702) Subject Walker Karen Marie (2008556) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/13/2026 3:18 PM | Kyverna Therapeutics (1994702) Filer | Form ARS | |
| 04/13/2026 3:02 PM | Kyverna Therapeutics (1994702) Filer | Form DEF 14A | |
| 04/13/2026 3:10 PM | Kyverna Therapeutics (1994702) Filer | Form DEFA14A | |
| 04/07/2026 3:05 PM | Kyverna Therapeutics (1994702) Subject SPIEGELMAN DANIEL K (1238403) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 11:15 PM | Kyverna Therapeutics (1994702) Filer | Form EFFECT | |
| 04/02/2026 3:48 PM | Kyverna Therapeutics (1994702) Filer | Form 424B5 | |
| 03/31/2026 4:09 PM | Kyverna Therapeutics (1994702) Subject SPIEGELMAN DANIEL K (1238403) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 3:26 PM | Kyverna Therapeutics (1994702) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/26/2026 3:22 PM | Kyverna Therapeutics (1994702) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 03/26/2026 3:11 PM | Kyverna Therapeutics (1994702) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/17/2026 3:30 PM | GEHCHAN NAJI (2052410) Reporting Kyverna Therapeutics (1994702) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:30 PM | Biddle Warner Weston (2034523) Reporting Kyverna Therapeutics (1994702) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/17/2026 3:30 PM | GRASSO MARC (1748894) Reporting Kyverna Therapeutics (1994702) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 5:51 PM | Kyverna Therapeutics (1994702) Subject Northpond Ventures III, LP (1972690) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 3:30 PM | Bain Capital Life Sciences Opportunities III, LP (1950105) Filed by Kyverna Therapeutics (1994702) Subject | Form SCHEDULE 13G/A | |
| 02/06/2026 2:17 PM | Kyverna Therapeutics (1994702) Subject Westlake BioPartners Fund I, L.P. (1749591) Filed by | Form SCHEDULE 13G/A | |
| 02/03/2026 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 4:00 PM | Kyverna Therapeutics (1994702) Issuer Shaw Christi (1702473) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 10:42 AM | Kyverna Therapeutics (1994702) Issuer Westlake BioPartners Fund I, L.P. (1749591) Reporting Westlake BioPartners GP I, LLC (2007650) Reporting Westlake BioPartners Opportunity Fund I, L.P. (1811946) Reporting Westlake BioPartners Opportunity GP I, LLC (1811945) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/22/2025 10:43 AM | Kyverna Therapeutics (1994702) Issuer SEIDENBERG BETH C (1184592) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
America's Biggest Bank… Down? (Ad) About 4,800 Chase customers reported problems in just 15 minutes on Monday. Many couldn't log in or move money, all because of one software bug at one bank.
Now think about how much you have sitting in that system, from your paycheck to your 401(k). It's your money. But you can only reach it when their system lets you. That's why our members don't leave it all inside the bank. See how to hold part of your savings where only you have the keys → |
| 12/17/2025 8:49 PM | Kyverna Therapeutics (1994702) Filer | Form 424B5 | |
| 12/17/2025 8:50 PM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/17/2025 7:30 PM | Kyverna Therapeutics (1994702) Issuer Walker Karen Marie (2008556) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/17/2025 7:52 AM | Kyverna Therapeutics (1994702) Subject | Form FWP | |
| 12/15/2025 4:29 PM | Kyverna Therapeutics (1994702) Filer | Form 424B5 | |
| 12/15/2025 3:16 PM | Kyverna Therapeutics (1994702) Subject Walker Karen Marie (2008556) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/15/2025 7:00 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/15/2025 5:30 AM | Kyverna Therapeutics (1994702) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |